Related Experiment Video
Updated: Feb 10, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12
Urszula L McClurg1,2, Nay C T H Chit3, Mahsa Azizyan3
1Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK. Urszula.McClurg@ncl.ac.uk.
Abstract:
The TP53-MDM2-AR-AKT signalling network plays a critical role in the development and progression of prostate cancer. However, the molecular mechanisms regulating this signalling network are not completely defined. By conducting transcriptome analysis, denaturing immunoprecipitations and immunopathology, we demonstrate that the TP53-MDM2-AR-AKT cross-talk is regulated by the deubiquitinating enzyme USP12 in prostate cancer. Our findings explain why USP12 is one of the 12 most commonly overexpressed cancer-associated genes located near an amplified super-enhancer. We find that USP12 deubiquitinates MDM2 and AR, which in turn controls the levels of the TP53 tumour suppressor and AR oncogene in prostate cancer. Consequently, USP12 levels are predictive not only of cancer development but also of patient's therapy resistance, relapse and survival. Therefore, our findings suggest that USP12 could serve as a promising therapeutic target in currently incurable castrate-resistant prostate cancer.
Insights
The deubiquitinating enzyme USP12 regulates the TP53-MDM2-AR-AKT network in prostate cancer. USP12 targets MDM2 and AR, impacting tumor suppressor and oncogene levels, and predicts patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The TP53-MDM2-AR-AKT signaling network is crucial in prostate cancer development and progression.
- The precise molecular mechanisms governing this critical signaling network remain incompletely understood.
Purpose of the Study:
- To elucidate the regulatory mechanisms of the TP53-MDM2-AR-AKT signaling network in prostate cancer.
- To investigate the role of the deubiquitinating enzyme USP12 in prostate cancer pathogenesis.
Main Methods:
- Transcriptome analysis
- Denaturing immunoprecipitations
- Immunopathology studies
Main Results:
- Demonstrated that USP12 regulates the TP53-MDM2-AR-AKT signaling cross-talk in prostate cancer.
- USP12 deubiquitinates both MDM2 and AR, thereby controlling TP53 tumor suppressor and AR oncogene levels.
- USP12 overexpression correlates with amplified super-enhancers and is among the top 12 cancer-associated genes.
Conclusions:
- USP12 levels are predictive of prostate cancer development, therapy resistance, relapse, and patient survival.
- USP12 represents a potential therapeutic target for castrate-resistant prostate cancer.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
GTPases and their Regulation
Large G-proteins,...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Epigenetic Regulation
What is Cell Signaling?

